Registration is now closed. You can still show up but priority will be given to those who have registered.
On Thursday March 23rd, Universities Allied for Essential Medicines will hold a half-day conference in honour of World TB Day. Following the keynote address by Stephen Lewis, Part I will highlight problems around access to drugs and diagnostics for TB. Part II will feature a panel focused on potential solutions along the research and development continuum – from bench to bedside. The interdisciplinary panel will discuss the potential role of alternative research and licensing frameworks as well as stakeholders across the public and private sectors.
This event will be co-hosted by McGill Global Health Programs, the McGill International TB Centre, Médecins Sans Frontières Canada, the McGill Institute for the Study of International Development and AIDS-Free World.
Speaker bios available here
Keynote address by Stephen Lewis, Co-director, AIDS-Free World
Madhukar Pai, Director, McGill Global Health Programs
Jennifer Furin, MD, PhD, Harvard University
Grania Brigden, 3P Project Lead, International Union Against Tuberculosis and Lung Disease
Rachel Kiddell-Monroe, Special Advisor, Universities Allied for Essential Medicines, Professor of Practice, McGill Institute for the Study of International Development
Jason Nickerson, Humanitarian Affairs Advisor, Médecins Sans Frontières Canada / Doctors Without Borders
Chris Walpole, Structure-Guided Drug-Discovery Coalition Project Lead, Structural Genomics Consortium
Rachel Cohen, Regional Executive Director, Drugs for Neglected Diseases Initiative North America
|Keynote address by Mr. Stephen Lewis||3.10 pm|
|Part I: Problems||3.45 pm|
|Part II: Solutions||4.40 pm|